Related Experiment Video

Updated: Sep 19, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 18, 2011

Proteasome-mediated degradation of BRCA1 protein in MCF-7 human breast cancer cells

Y H Choi1

  • 1Department of Biochemistry, College of Oriental Medicine, Dong-Eui University, Pusan 614-054, Korea. choiyh@hyomin.dongeui.ac.kr

International Journal of Oncology
|September 20, 2001
PubMed

Insights

The breast and ovarian cancer gene BRCA1 is rapidly degraded via the ubiquitin-proteasome pathway. Proteasome inhibitors prevent BRCA1 protein loss, indicating its role in tumor suppression.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • BRCA1 is a crucial tumor suppressor gene involved in breast and ovarian cancer susceptibility.
  • Understanding the regulation of BRCA1 protein levels is vital for cancer research.

Purpose of the Study:

  • To investigate the mechanism of BRCA1 protein degradation.
  • To determine if the ubiquitin-proteasome pathway is involved in BRCA1 turnover.

Main Methods:

  • Utilized specific proteasome inhibitors (MG-132, ALLnL) in human MCF-7 breast carcinoma cells.
  • Assessed BRCA1 protein levels following treatment with proteasome inhibitors and other agents (taxol, okadaic acid, nocodazole).
  • Examined the localization and modification (ubiquitination) of BRCA1 protein.

Main Results:

  • Proteasome inhibitors significantly increased BRCA1 protein levels, indicating rapid degradation.
  • Proteasome inhibitors prevented the enhanced loss of BRCA1 induced by taxol, okadaic acid, or nocodazole.
  • BRCA1 degradation and accumulation of ubiquitinated species were observed primarily in the nucleus.
  • The half-life of BRCA1 protein was significantly extended upon proteasome activity inhibition.

Conclusions:

  • BRCA1 protein is degraded through the ubiquitin-proteasome mediated pathway.
  • This degradation mechanism is primarily localized to the nucleus.
  • Findings provide insights into the post-translational regulation of the BRCA1 tumor suppressor.

More Related Videos

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

Related Concept Videos

The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...